Reyes, K. R., Zhang, L., Cai, E. Y., Thomas, Z., Jiang, C. Y., Oh, E., Jindal, T., Zhong, J. Y., Jaime-Casas, S., Milowsky, M. I., Nizam, A., Shah, S., Basu, A., Grivas, P., Tripathi, A., Brown, J. R., Alhalabi, O., Tsung, I., Campbell, M. T., Koshkin, V. S. (2026). Impact of HER2 expression and
                    <i>ERBB2</i>
                    alterations on clinical outcomes in patients treated with enfortumab vedotin and pembrolizumab (EVP): UNITE study analysis.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.794